Please ensure Javascript is enabled for purposes of website accessibility

Why Kimberly Clark Corp. Stock Gained 13% in 2017 So Far

By Demitri Kalogeropoulos - Jul 18, 2017 at 12:21PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

While sales growth is slowing, investors are focusing instead on the consumer products company's rising profitability.

What happened

Consumer products giant Kimberly-Clark (KMB -0.76%) stock added 13% through the first half of 2017, according to data provided by S&P Global Market Intelligence.

The boost has helped shareholders recover some of ground they lost after the Huggies and Kleenex brand owner underperformed the market by a wide margin in 2016.

KMB Chart

KMB data by YCharts

So what

Kimberly-Clark hasn't posted a sales rebound this year. In fact, its growth pace is slowing.

Organic sales rose by just 2% in fiscal 2016, the company announced in late January, compared to a 5% gain in 2015. The good news is that Kimberly-Clark still hit its earnings growth target, thanks to aggressive cost cutting. It successfully defended its market position from rivals, too. "While we experienced a challenging economic and competitive environment in 2016," CEO Thomas Falk said in a press release, "our market share positions remained broadly healthy."

A baby has its diaper changed.

Image source: Getty Images.

Its first-quarter report paired more bad news on the growth front with steady earnings gains. Organic sales declined by 1% due to surprising weakness in its core U.S. market. Yet profitability ticked higher, and net income improved by 3% to $563 million.

Now what

Kimberly-Clark in late April lowered its full year outlook; it's now targeting growth of between 1% and 2% rather than the firm 2% that CEO Thomas Falk and his executive team had originally projected. Investors aren't faulting the company for this slowdown, especially since its major peers, including Procter & Gamble and Clorox, are pulling back their forecasts due to the same disappointing industry trends.

While Kimberly-Clark's stock has outperformed these rivals so far this year, it will likely take a rebound in sales growth for shares to see market-beating gains over the long term.

Demitrios Kalogeropoulos has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Kimberly-Clark Corporation Stock Quote
Kimberly-Clark Corporation
KMB
$134.63 (-0.76%) $-1.03

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
390%
 
S&P 500 Returns
125%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/11/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.